TY - JOUR
T1 - Moderators of Treatment Outcomes After Telehealth Self-Management and Education in Adults With Multiple Sclerosis
T2 - A Secondary Analysis of a Randomized Controlled Trial
AU - Ehde, Dawn M.
AU - Arewasikporn, Anne
AU - Alschuler, Kevin N.
AU - Hughes, Abbey J.
AU - Turner, Aaron P.
N1 - Funding Information:
Supported by the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research (grant no. H133B080025); and by a fellowship grant from the National Multiple Sclerosis Society (grant no. MB 0026).
Publisher Copyright:
© 2018 American Congress of Rehabilitation Medicine
PY - 2018/7
Y1 - 2018/7
N2 - Objective: To examine moderators of treatment effects in a randomized controlled trial comparing a telehealth self-management intervention with a telehealth multiple sclerosis (MS) education intervention for fatigue, pain, and mood in adults with MS. Design: Secondary analysis of a single-blind randomized controlled trial. Setting: Community. Participants: Adults with MS and chronic fatigue, chronic pain, and/or moderate depressive symptoms (N=163) recruited from across the United States. Interventions: Two 8-week, telephone-delivered symptom interventions delivered 1:1: a self-management intervention (n=75) and an MS education intervention (n=88). Main Outcome Measures: Outcome measures were fatigue impact pain interference, and depressive symptom severity assessed at baseline and posttreatment. Potential moderators of treatment effects assessed at baseline were demographics (age, sex, and education), clinical characteristics (disease duration and disability severity), symptoms (perceived cognitive impairment and pain intensity), baseline levels of the treatment outcomes (pain interference, fatigue impact and depressive symptom severity), and cognitive behavioral factors (pain catastrophizing, fatigue catastrophizing, self-efficacy, and patient activation). Results: Moderation analyses found significant moderation for fatigue impact but not for pain intensity or depressive symptom severity. Baseline patient activation interacted with treatment group to predict fatigue impact at posttreatment (P=.049). Among participants with high baseline patient activation, the self-management group reported significantly less fatigue at posttreatment than the education group. No other variables moderated the study outcomes. Conclusions: At the group level, participants responded to both interventions, regardless of disease characteristics, demographics, symptom levels, and cognitive behavioral factors. Self-management and education are both potentially beneficial symptom treatments that may be recommended to individuals with MS and chronic pain, fatigue, and/or depressive symptoms.
AB - Objective: To examine moderators of treatment effects in a randomized controlled trial comparing a telehealth self-management intervention with a telehealth multiple sclerosis (MS) education intervention for fatigue, pain, and mood in adults with MS. Design: Secondary analysis of a single-blind randomized controlled trial. Setting: Community. Participants: Adults with MS and chronic fatigue, chronic pain, and/or moderate depressive symptoms (N=163) recruited from across the United States. Interventions: Two 8-week, telephone-delivered symptom interventions delivered 1:1: a self-management intervention (n=75) and an MS education intervention (n=88). Main Outcome Measures: Outcome measures were fatigue impact pain interference, and depressive symptom severity assessed at baseline and posttreatment. Potential moderators of treatment effects assessed at baseline were demographics (age, sex, and education), clinical characteristics (disease duration and disability severity), symptoms (perceived cognitive impairment and pain intensity), baseline levels of the treatment outcomes (pain interference, fatigue impact and depressive symptom severity), and cognitive behavioral factors (pain catastrophizing, fatigue catastrophizing, self-efficacy, and patient activation). Results: Moderation analyses found significant moderation for fatigue impact but not for pain intensity or depressive symptom severity. Baseline patient activation interacted with treatment group to predict fatigue impact at posttreatment (P=.049). Among participants with high baseline patient activation, the self-management group reported significantly less fatigue at posttreatment than the education group. No other variables moderated the study outcomes. Conclusions: At the group level, participants responded to both interventions, regardless of disease characteristics, demographics, symptom levels, and cognitive behavioral factors. Self-management and education are both potentially beneficial symptom treatments that may be recommended to individuals with MS and chronic pain, fatigue, and/or depressive symptoms.
KW - Chronic pain
KW - Depression
KW - Fatigue
KW - Multiple sclerosis
KW - Rehabilitation
KW - Self-management
UR - http://www.scopus.com/inward/record.url?scp=85046171029&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046171029&partnerID=8YFLogxK
U2 - 10.1016/j.apmr.2017.12.012
DO - 10.1016/j.apmr.2017.12.012
M3 - Article
C2 - 29337024
AN - SCOPUS:85046171029
SN - 0003-9993
VL - 99
SP - 1265
EP - 1272
JO - Archives of Physical Medicine and Rehabilitation
JF - Archives of Physical Medicine and Rehabilitation
IS - 7
ER -